Somatostatin

Somatostatin

Somatostatin

Min.Order / FOB Price:Get Latest Price

1 Gram

Negotiable

  • Min.Order :1 Gram
  • Purity: 99% purity
  • Payment Terms : T/T,,MoneyGram,Other

Keywords

panhibin 51110-01-1 99% purity

Quick Details

  • Appearance:powder
  • Application:API
  • PackAge:According to the need to packing
  • ProductionCapacity:100|Kilogram|Month
  • Storage:sealed,dry,low temperature
  • Transportation:air,sea and courier

Superiority:

Somatostatin Basic information

Discovery Structure Gene, mRNA, and precursor Clinical implications Receptors Biological functions Regulation of synthesis and release
Product Name:    Somatostatin
Synonyms:    panhibin;M.W. 1637.80 C76H104N18O19S2;CCRIS 3629;Somatostatin;Anti-Somatostatin, N-Terminal antibody produced in rabbit;SOMATOSTATIN [GIF];SOMATOSTATIN (HUMAN, OVINE, PORCINE, RAT, MOUSE);SOMATOSTATIN (HUMAN, OVINE, PORCINE, RAT, MOUSE) 2ACOH 6H2O
CAS:    51110-01-1
MF:    C76H104N18O19S2
MW:    1637.88
EINECS:    256-969-7
Product Categories:    
Mol File:    51110-01-1.mol

Details:

Somatostatin Chemical Properties
storage temp.     −20°C
solubility     H2O: 1 mg/mL
form     powder

Safety Information
Hazard Codes     Xi
Risk Statements     36/37/38
Safety Statements     26-36
WGK Germany     3
RTECS     WF8751700
F     3-10-21

Description    Originally isolated from hypothalamic tissue, somatostatin is characterized as an inhibitor of growth hormone (GH) release. The structure was determined in 1971. Subsequent investigations led to the recognition that somatostatin also was released from the pancreas and has a role of inhibiting the secretion of both insulin and glucagon. A total of five somatostatin receptor subtypes have been characterized and cloned (sst1 to sst5). Subtype sst4 is associated with the inhibition of insulin release, and an sst4-selective inhibitor has been reported. The somatostatin analogue SOM230 has exhibited selectivity for sst1, sst2, sst3, and sst5 in rats and effectively decreased plasma GH and insulin-like growth factor-1 (IGF-1) levels by 75% without significant effects on insulin or glucagon. Another analogue, PT R3173, with selectivity for recombinant human somatostatin receptor (hsst2, hsst4, hsst5) was substantially more effective in inhibiting GH secretion compared to glucagon and insulin release in rats.
Uses    Somatostatin is a peptide hormone that regulates the endocrine system

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View